Genomic Medicine

This week’s Science has a special feature on genomic medicine (for subscribers only).

Eliot Marshall’s article "First Check My Genome, Doctor" briefly discusses trends related to the development of DNA diagnostics.  A person’s genetic allotment may help doctors determine the effectiveness of drugs, including the severity of side effects. 

For example, recent evidence indicates that DNA diagnostics may be useful for predicting whether patients will respond favorably to anti-depressants.

A handful of companies are in the process of developing such diagnostics.  The article mentions several:   

Roche Molecular Diagnostics
AmpliChip CYP450
(press release)

Seryx
Signature Genetics
(web)

Genaissance Pharmaceuticals
(web)

Gentris
(web)

 

Comments

Comments are closed.